Author: admin

Event

World EPA Congress 2023

Post author By admin
Post date February 15, 2023

World EPA Congress

Let’s meet at Booth 51

Join us at the the World EPA Congress where we’ll be sharing the latest insights from the Access Infinity team on industry hot topics.

Join us on Day 1, 11:45 to hear from our team on:

“What’s the state of market access performance tracking in 2023?”

Today’s market access professionals are working incredibly hard to secure the best price and broadest access for their brands. It’s no secret that there are often obstacles to overcome, not to mention rising expectations and targets that are putting the function under increased pressure to deliver.

With all this in mind, how can you improve the success of something that isn’t measured?

It’s a subject that’s close to our hearts at Access Infinity. We see first-hand the positive impact that effective KPI tracking has in helping teams achieve faster access and better prices for their products.

At this year’s EPA Congress, we’ll provide an overview of the state of market access performance today, focusing on:

The role of market access performance tracking and why it’s important for your success
How to plan your own launch goals and targets, with guidance on the most impactful KPIs and metrics
How to assess and measure your global market access performance across a launch
Why 2023 is your year to become a market access performance champion for your business.

Join the Access Infinity team at RAI Congress Centre Amsterdam 21st – 23rd March.

Meet our speakers

Shri Rao Mukku

Founding Director

Shri Rao Mukku is a Founding Director at Access Infinity and has 14+ years of consulting and industry experience. Shri worked at Merck as Global Director, MAP (Market Access and Pricing) and was responsible for Erbitux and other oncology products and at Lundbeck as ‘Pricing Specialist’ in the Global Pricing team.

Shri’s consulting experience includes launch pricing strategy, country and indication sequencing, qualitative research on value proposition development, value messaging, impact of clinical evidence generation on product value assessment, post LoE (loss of exclusivity) pricing strategy & assessment of new products for BD opportunities (in-and out-licensing). He has also established and/or led pricing and market access departments of different consulting companies such as Access Partnership & Double Helix Consulting.

Thomas Gilboy

Digital Solutions Product Owner

Thomas Gilboy is the Product Owner at Access Infinity for our Market Access Digital Tools. As Product Owner, he leads the product development and leads the product development leads the product development and “blue sky thinking” of what is possible within the digital space for Market Access. Before Access Infinity, Tom worked for 10 years within Market Access in consulting and at ViiV. In consulting Tom delivered over 100 projects covering a broad range of Market Access topics from early pipeline decisions through to end of life cycle planning, across a broad range of therapy areas. At ViiV, Tom covered the successful European Market Access for one of their launching HIV brands.

Join us on Day 2, 14:55 to hear from our team on:

“Analogue analysis dos and don'ts"

Our presentation on day 2 will focus on the needs of early market access teams, taking a deeper dive into how to produce more accurate analysis and evidence to support a product’s launch strategy, at pace.

In today’s pharma companies, the Market Access and Pricing function is providing a vital bridge between clinical and commercial functions. Analogues need to be considered at every stage, so that influencing drivers for price and market access can be evaluated.

In this session, our Founding Director Shri Rao Mukku will explore best practices in analysing analogues, as well as uncover the common mistakes we see in industry, offering our advice for how to avoid them.

Join the Access Infinity team at RAI Congress Centre Amsterdam 21st – 23rd March.

Best practices in estimating pipeline product prices for early market access teams

It goes without saying that analogues are a great choice for robust evidence because they tell us what’s historically happened to products in similar situations. Of course, there is no perfect analogue that 100% meets your own product, so how do you choose which ones to analyse and review?
There’s much to consider and a lot at stake, not to mention the time pressures you’re facing to answer complex questions, at pace.
So how can early market access professionals take a holistic approach to finding the right analogues in the right time frame?
Our Product Owner Thomas Gilboy explores this at EPA Congress, taking a deeper dive into:
· The analogue analysis challenges faced by today’s early market access teams[LB1]
· How to produce more accurate analysis and evidence to support a product’s launch strategy
· How to pick up the pace of analogue analysis [LB2] so that you can respond rapidly and accurately to enquiries from the [launch?] team

Let’s meet in person

The World EPA Congress 2022 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.

Meet us at Booth 20.

About Access Infinity

Access Infinity is the world leader of digital transformation in the Pharma Industry. We are a trusted provider of digital platforms and consulting services to leading pharma companies

Our products and services

Consulting

The critical support you need to develop a successful value assessment and launch strategy.

Digital products

Our cloud-based apps for rapid business intelligence, KPI tracking, access and evidence planning.

We look forward to meeting you

The World EPA Congress 2023 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.

Join us

Analyst/Senior Analyst/Associate Consultant – Market Access and Pricing

Post author By admin
Post date January 31, 2023

Applications are now closed, however if you are interested in working at Access Infinity, please share your CV and a covering letter and we will reach out when applications reopen.

What we can offer

A leadership team with more than half a century of the highest-level pricing and market access experience means that Access Infinity is a great place to develop your skills in the field as part of our innovative and growing team.

We have a strong training and development programme with 20+ learning modules to give you the best start to your global market access career. These include subject matter training in market access and pricing as well as transferable skills such as project management and presentation writing
You will learn the best practices in project management from true leaders in the industry, in a friendly and fun environment
Support will always be available from the senior team in an accessible, flat company structure
Development opportunities and performance/promotion reviews to accelerate your development
We believe in rewarding high performance and offer a generous compensation package

About you:

We are looking for people who have a proactive, solution-oriented approach, are great at managing their time and strong communicators.

What we are looking for:

Essential:

Likely 0 (Analyst) to 3 (Associate Consultant) years experience in global strategic market access consultancy
Some experience delivering international primary research
Experience researching medical and life science information (scientific and clinical literature, drug development pipelines, health system decision-making
Experience using Microsoft Excel and similar tools for numerical analysis
Experience using Microsoft PowerPoint and similar tools for presentations
Excellent written and spoken English
An ambitious team player with a track record of working as part of a team

Ideal:

Experience analysing HTA decision-making and outcomes (Senior Analyst and above)
Experience interviewing payers and clinical experts (Associate Consultant)
Understanding of clinical trial process
Familiarity with the structure and function of some international health systems (Senior Analyst/Associate Consultant)
Experience working as part of a team in a remote or mixed working model.

Please email your CV and cover letter along to [email protected] with the Role you are applying for as the subject

Blog

The 8 Market Access Performance Metrics You Should Be Tracking

Post author By admin
Post date August 24, 2022

Here Are 8 Essential KPIs Your Market Access Teams Should Be Looking At

The route to market for any given drug is rarely a straight line. There are many obstacles to overcome and expectations are high. You need to achieve the best price and broadest possible access in the shortest possible time across the greatest number of markets, all the while communicating value to payers.

There is much to do leading up to dossier submission, including getting your evidence strategy right, developing CE/BI models, payer value story, P&R strategy, and much more – work that starts years before launch.

So it’s no surprise that some areas of market access don’t get the attention they deserve. In fact, the whole area of market access performance isn’t on the radar for 90% of market access teams. By ‘market access performance’, we mean tracking a number of key metrics to achieve the following:

Deliver critical insights to help track as well as shape your launch strategy.
Demonstrate performance of the access function in numbers.
Learn from past mistakes and be better prepared for future launches.
Make the access function more successful and improve the chances of achieving your P&R goals.

Where Market Access KPIs Fit In

You’re a global market access director and are responsible for the P&R strategy for your drug. You’re launching next year and you’ve done everything you can to dot the i’s and cross the t’s. You’re feeling nervous, but confident in the strategy you’ve put in place. Now the regulatory approvals come in thick and fast and the race is on to get your product through submission, contract negotiation and into reimbursement lists at a price that’s in line with your strategy.

But how do you know if you’ve done a good job? How well did you actually perform on your objectives? This is where KPIs (Key Performance Indicators) come in.

By not implementing KPIs you’re missing out on valuable insights that could help you understand how well you’re performing on key access metrics. You’re also losing an opportunity to further refine your strategy throughout the launch phase.

Thankfully, it is easier to track performance than you might think. In fact, you don’t need to put in any extra time or effort to track KPIs. There are tools out there to help.

But first, you need to know what to track. You might be monitoring some of them already. But it’s unlikely you’re tracking all of them.

The 8 KPIs You Should Track

These 8 KPIs aren’t something we dreamt up one afternoon. They are the result of a long journey, following many years of helping top brands track performance and conducting hundreds of interviews across global and country teams.

Including these KPIs for your own products will give you a more complete picture of how well your launch is going and enable you to make improvements for the future.

We split the 8 KPIs into three groups addressing the most common P&R objectives. They are: Speed-of-access, Breadth-of-access and Price Performance. The diagram below provides a visual summary:

To access the full guide, fill the form below and you will receive it by email.

Blog

GETTING MORE OUT OF YOUR ANALOGUE ASSESSMENTS WITH NURO

Post author By admin
Post date August 9, 2022

GETTING MORE OUT OF YOUR ANALOGUE ASSESSMENTS WITH NURO

‘What pricing opportunities do I have when launching in a highly genericised landscape?’

‘What does differentiation look like in a crowded market place?’

‘If my clinical comparator is off label, how do I support a trial design that is acceptable to payers?’

These can be difficult questions to tackle. Often, the first place to look for answers are analogues, i.e. what other products faced a similar situation and what can we learn from them? Finding good analogues (or even no analogues!) can go a long way in better informing your market access strategy and in developing stronger business cases internally.

Below, I’ve put together some considerations and best practices we apply ourselves while conducting analogue assessments.

Create a robust set of matching criteria

Before embarking on any assessment the first step is to make a thorough list of criteria that characterise your situation. Defining criteria by ‘product/disease characteristics’ and ‘launch environment’ can often be a good place to start.

Define product/disease characteristics

Define the launch environment

Size of target population
Number of other indicated products
Availability of generic price benchmarks
Launch indication or follow-on indication
Parallel or sequential launch of indication
Competitors using active comparator or placebo in clinical trials
Off-label/on-label comparators

The list above is not comprehensive

You may choose to apply a very broad matching criteria (e.g. products with orphan designation regardless of therapy area) or be very specific (e.g. products that are small molecule, oncology, oral-only, launched in at least two indications simultaneously, having used active comparators in pivotal trials)

Either way, this sets up the basis of your analogue search. The next step is to apply this criteria to a reference data set. To make the best business case for your assessment, use either the EMA or FDA drug databases (or both) as your starting point.

Be comprehensive and systematic in applying the criteria

It’s important to take a comprehensive approach (e.g. start with all EMA or FDA approved products) to avoid cherry-picking only those analogues you are already aware of. It’s equally important to be systematic in applying the matching criteria to ensure repeatability of the exercise and build defendable business cases.

In taking this approach, what you normally get is a ‘funnel’ that starts with a very large dataset and ends with a manageable shortlist of analogues for you to deep-dive into. For instance, let’s imagine you’re looking for examples of non-orphan biologic products in selected therapy areas that achieved an ASMR III or higher having submitted only placebo controlled pivotal studies. Your analogue selection funnel might look something like this:

Be aware of the limitations: think directional insights

It’s tempting to look to analogues to answer all your questions. More often than not they’re there to shine light on some, often critical, aspects and to reduce that cloud of uncertainty surrounding your business objectives. After all, you’re bringing a new product to market with characteristics that are unique to it. But despite their limitations, analogues can be a source of great insights that support a better understanding of your product’s price and access opportunities. The exercise also gives you valuable arguments in situations such as when leadership expects a price you know will be difficult to achieve or perhaps in convincing the clinical team about the importance of ‘hard endpoints’ in payer negotiations.

Having done several projects where finding analogues have generated critical insights, we recently launched a digital solution called Nuro that helps identify analogues for your products rapidly. The hypothetical funnel I created above, for instance, can be built and relevant analogues identified in a matter of minutes using Nuro.

About the author

Ahmed Edathodu
Founding Director at Access Infinity

Book a demo today and experience the breadth of our apps.

Join us

Analyst/Senior Analyst (Pricing & Reimbursement)

Post author By admin
Post date May 23, 2022

What we can offer:

We have a strong training and development programme with 20+ learning modules to give you the best start to your global market access career. These include subject matter training in market access and pricing as well as transferable skills such as project management and presentation writing
You will learn the best practices in project management from true leaders in the industry, in a friendly and fun environment
Support will always be available from the senior team in an accessible, flat company structure
Development opportunities and performance/promotion reviews to accelerate your development
We believe in rewarding high performance and offer a generous compensation package

About you:

We seek experienced candidates having a thorough insights in global pharma pricing, reimbursement, and cost of therapy to fill this position. An understanding of market regulation for pharmaceuticals, indication-based reimbursement, health technology assessment process in major markets is an advantage.

What we are looking for:

Key Responsibilities

Collect and track pharma pricing data from databases around the world.
Collect and track changes in the market regulation for pharmaceuticals across various markets around the world.
Secure access to sources and look for alternative sources for pricing & reimbursement.
Data gathering via primary and secondary research and data analysis in support of client projects.
Timely data update, data collection process optimization & process automation.
Pricing & Reimbursement reports, including data pulling, standardization & calculations
Updating, pricing & reimbursement information required to keep update and maintenance of NURO tool
Performing COT (cost of treatment) calculations based on secondary research and robust assumptions.

Competencies:

2-4 years’ experience in pricing and market access domain (global pharma pricing & reimbursement)
Payer Management Expertise (Pricing) – Understands specific price setting mechanisms in key markets. Demonstrates knowledge of drivers for price and access for payer stakeholders.
Pricing & Contracting (Pricing) – Employs specific tools (pricing and contracting, price optimization models, etc.) to generate and analyze pricing and reimbursement insight.
Good level of understanding in MS Excel, knowledge of Excel VBA programming will be a value addition.
Detailed oriented, rapid response kind of attitude.
Excellent in stakeholder communication with strong inter-personal skills
A positive attitude, multi-tasking ability and taking ownership of assigned tasks
Education (minimum): Undergraduate degree in a relevant scientific discipline plus graduate degree (Masters)

Please email your CV and cover letter along to [email protected] with the Role you are applying for as the subject

Join us

Project Manager

Post author By admin
Post date May 16, 2022

About us

Access Infinity is a boutique Pricing and Market Access consultancy based in London, with an office in Hyderabad, India and partners in the US. We have two business verticals:

Consulting – delivering exceptional consultancy projects to the leading companies in Pharma

Digital Tools – paving the way for innovative digital tools through cloud-based apps that enable our clients to strategically track the launch of new drugs

The role

We are seeking mid-level Project Manager to join our fast-growing Digital Solutions team, to handle multiple internal and client projects. You will be working across our portfolio of digital tools;

• Global Market Access KPI tracker that enables monitoring and dashboarding of key reimbursement metrics at global, regional and country level

• A project management solution enabling teams to track real world evidence projects and timelines

• A data platform that enables users to analyse analogues and carry out competitive benchmarking out of the box

Responsibilities

Responsible for on-time, on-budget project delivery – in line with internal KPIs and targets
Work with stakeholders and external partners for accurate scoping of projects
Work with Business Analysts, UX Designers and Product Owners to create and maintain project documentation
Work closely with stakeholders and Program Manager to prioritize projects, schedule and orchestrate projects
Work closely with Program Manager to effectively plan and manage engineering resources
Proactively manage tasks and resources, in line with project scope and delivery schedule
Support the definition, implementation and governance of delivery processes
Implement innovative ways of working throughout the project lifecycle
Experience of Set-up, planning and scheduling projects within Jira or Azure DevOps
Drive client communications around project status and performance
Status Reports, Project health (time and money) reports and end of project wrap up reports
Work closely with team to analyse technical issues and facilitate team to come up with solutions

Competencies:

Overall 6-10 years of experience with Project Management experience of 3-5 years
Project Management experience on .Net platform or Java platform – hands-on experience must
Fair knowledge of MS SQL Server or other RDBMS platform – hands-on experience must
Good knowledge of waterfall SDLC processes and related documentation
Working knowledge of Agile processes and ceremonies – Agile experience is a plus
Excellent Oral and Written English communication skills
PMP, Prince II (or equivalent) or CSM qualification is desirable
Quality assurance testing understanding / experience is an advantage
Experience working on creation / maintenance of a software product is an advantage
Experience of creating functional and technical specifications with the UX and development teams
Must be a team player willing to get hands dirty

To apply, please send your CV and cover letter detailing relevant experience to [email protected]

Event

World EPA Congress 2022

See our Founding Director’s talk

“Showcasing the success of your brand through market access KPIs”

The Market Access function works incredibly hard to get the price & reimbursement strategy right for each brand. However, often struggles to measure its own successes and showcase them to the wider organisation.

Perhaps you are unsure about why it is important to measure Market Access KPIs, or maybe you don’t know which KPIs to measure?

Join Ahmed at the EPA congress where he will guide you through measuring Market Access successes easily and, more importantly, well.

Ahmed Edathodu

Ahmed Edathodu is a Founding Director at Access Infinity. Having worked in senior positions within market access in Big Pharma and strategy consulting companies, Ahmed co-founded Access Infinity and has been instrumental in developing its global pricing and reimbursement practice. Prior to starting Access Infinity, he worked at Janssen Pharmaceuticals (Johnson and Johnson’s Pharmaceutical arm) where he supported the EMEA team in launching Rezolsta as well as and market access strategy planning for Janssen’s full HIV portfolio.

In consulting, Ahmed has worked extensively in developing market access strategies for over 100 products in 12+ years covering all major geographies and with a focus on European and APAC markets. He also leads the product thinking behind AI’s digital products NURO and Access Hub. Ahmed holds an MPhil in Bioscience Enterprise from the University of Cambridge and an MSc in Biochemical Engineering.

Let’s meet in person

The World EPA Congress 2022 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.

Meet us at Booth 20.

About Access Infinity

Access Infinity is the world leader of digital transformation in the Pharma Industry. We are a trusted provider of digital platforms and consulting services to leading pharma companies

Our products and services

Consulting

The critical support you need to develop a successful value assessment and launch strategy.

Digital products

Our cloud-based apps for rapid business intelligence, KPI tracking, access and evidence planning.

We look forward to meeting you

The World EPA Congress 2022 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.

Join us

Consultant/Senior Consultant/Associate Director – Market Access and Pricing

Post author By admin
Post date March 16, 2022

Applications are now closed, however if you are interested in working at Access Infinity, please share your CV and a covering letter and we will reach out when applications reopen.